MEDIROM Attracts M3 to Series A Funding Round

MEDIROM Healthcare Technologies (MRM) has released an update.

MEDIROM Healthcare Technologies has announced that M3, Inc. is joining the Series A financing round for its subsidiary, MEDIROM MOTHER Labs, with a significant pre-money valuation of JPY9 billion, approximately USD 59 million. This investment highlights the growing interest in health-tech innovations, particularly those offered by MOTHER Labs, which focuses on customizable health management solutions through its recharge-free MOTHER Bracelet smart tracker. Investors in the financial markets may find this development noteworthy as it underscores MEDIROM’s strategic expansion in the health-tech sector.

For further insights into MRM stock, check out TipRanks’ Stock Analysis page.